Repligen Corp (NASDAQ:RGEN)

36.65
Delayed Data
As of Jul 28
 +0.55 / +1.52%
Today’s Change
18.23
Today|||52-Week Range
42.48
+85.10%
Year-to-Date

Today’s Trading

Previous close36.10
Today’s open36.41
Day’s range-- - --
Volume375,397
Average volume (3 months)386,479
Market cap$1.2B
Dividend yield--
Data as of 07/28/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+32.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio179.5
Price/Sales10.36
Price/Book10.59

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc+1.79+5.04%
CLLSCellectis SA+1.51+4.33%
HRTXHeron Therapeutics I...+1.59+4.92%
MACKMerrimack Pharmaceut...+0.16+1.58%
Data as of 07/28/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)$0.08
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
Tony J. Hunt
Chief Financial Officer
Jon K. Snodgres
Corporate headquarters
Waltham, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers